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Abstract: Sucrose octa(N-ethyl)carbamate was synthesized directly from sucrose and ethyl isocy-
anate, and its structure was confirmed by various analytical methods, such as 1H and 13C NMR, FTIR, 
m.p., MS, and optical rotation. Its antibacterial, antifungal and cytotoxic activities were investigated. It 
exhibited strong inhibition against all bacteria tested, namely S. aureus (MIC 0.18±0.006), B. cereus 
(MIC 0.094±0.000), M. flavus (MIC 0.28±0.01), L. monocytogenes (MIC 0.18±0.006), P. aeruginosa (MIC 0.094±0.002), 
S. typhimurium (MIC 0.094±0.002), E. coli (MIC 0.18±0.006) and E. cloacae (MIC 0.18±0.006) and strong antifungal ac-
tivity towards T. viride (MIC 0.09 ± 0.006), A. versicolor (MIC 0.18 ± 0.01), A. ochraceus (MIC 0.375 ± 0.01) and P. 
ochrochloron (MIC 0.375 ± 0.04). Furthermore, it showed moderate antitumor potential against human breast (GI50 
357.20±14.12), colon (GI50 332.43±11.19) and cervical (GI50 282.67±3.97) cell lines and, more important, without hepa-
totoxicity. 
Keywords: Biological activity, antimicrobial activity, cytotoxic activity, carbamate, carbohydrates, microwave chemistry,  
sucrose derivatization. 
1. INTRODUCTION 
The excessive or careless use of antibiotics has contrib-
uted to an increased number of drug resistant microorgan-
isms. Although many efforts have been devoted to overcom-
ing this worldwide issue, the present antimicrobial drug 
market is becoming inadequate and therefore it is necessary 
to develop new, safe and effective antibacterial and antifun-
gal compounds [1]. Cytotoxic agents for chemotherapy also 
attract much attention, since cancer is responsible for many 
deaths worldwide [2]. Recently, there has been an increasing 
interest in the development of therapeutic compounds that 
are biodegradable and biocompatible, derived from plant 
resources and natural compound-based substances [3]. A 
growing number of compounds with carbamate linkages 
have shown strong antimicrobial and cytotoxic activities 
have been reported [4-7].  
Various glycosides can be found in natural resources, 
mainly in the form of glycoconjugates, where the saccharide 
moiety plays an important role in modulating their biological 
activities [8]. Glycosyl carbamates find applications as do-
pamine prodrugs [9], surfactants [10], glycosyl donors [11], 
for studying carbohydrate–protein interactions [12], in gly- 
copeptide synthesis, [13] or for binding various residues 
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[14]. Their application to these studies results from their sta-
bility under basic conditions [15]. Methods for the synthesis 
of glycosyl carbamates from glycosyl carbonates [16] and 
from the corresponding lactol and isocyanate in the presence 
of a base [17] have been reported. The structures of the men-
tioned glycosides are presented in (Fig. 1). 
The wide variety of potent biological activities of natural 
and synthetic sugar derivatives encouraged us to develop 
novel biological active compounds based on sucrose [18, 
19]. It is a biorenewable and biocompatible raw material and 
is a promising starting material for the synthesis of new 
compounds with biological activity [20]. Sucrose carbama-
tion has been accomplished by reacting sucrose with isocy-
anates in dipolar aprotic solvents [21] and in water or mix-
tures of water and a co-solvent to obtain them chemoselec-
tively [22, 23].  
Herein, a model study on the polysubstitution of sucrose 
with ethylcarbamate moieties both under microwave irradia-
tion and conventional conditions is presented. The antimi-
crobial, antifungal and cytotoxic activities of the products 
were tested and compared with those of commercial agents – 
streptomycin and ampicillin (antimicrobial), bifonazole and 
ketoconazole (antifungal), and ellipticine (cytotoxic).  
2. RESULTS AND DISCUSSION 
2.1. Chemistry 
A comparison of the results of experiments carried out 
under microwave irradiation and conventional heating for the 
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formation of sucrose octa(N-ethyl)carbamate (Scheme 1) are 
presented in Table 1. 
Although we experimented the carbamate synthesis de-
scribed by Christian et al. in water-alcohol mixtures [22], we 
did not obtain the desired product probably because the iso-
cyanate reacted with the hydroxylic solvents. Therefore, a 
synthesis using a polar aprotic solvent such as pyridine was 
attempted, and the desired sucrose octa(N-ethyl)carbamate 
was formed in good yield (Scheme 1). Under these condi-
tions only the octa-substituted product, and not a mixture of 
compounds with different degrees of substitution, was 
formed. Both microwave assisted and conventional (room 
temperature) syntheses proceeded smoothly in pyridine using 
triethylamine as a base. Carbamation at room temperature 
was complete within 28 h and yielded 89 % octacarbamate. 
Increasing the reaction temperature did not lead to better 
results because degradation processes occurred. Although 
microwave irradiation usually leads to higher yields, in this 
case the reaction was not complete and some of the starting 
material was recovered. Thus, the octacarbamate was synthe-
sized under microwave irradiation in 15 min to afford only a 
69 % yield. Further irradiation for longer times did not lead 
  
Fig. (1). Structures of some synthetic glycosyl carbamates found in the literature. 
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Scheme 1. Synthesis of sucrose octa(N-ethyl)carbamate. 
Table 1. Comparison of the results from conventional conditions and microwave assisted synthesis (EtNCO, Et3N, pyridine, r.t. or 
MW). 
 Reaction Temperature Reaction Time Yield 
Conventional synthesis 20 °C 28 h 89 % 
Microwave irradiation 
(300 W) 
105 °C 15 min 69 % 
O
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to higher yields and the conditions reported here are the ones 
which provided the optimum results. Despite the somewhat 
lower yield using microwave irradiation, the drastic decrease 
in the reaction time is noteworthy. 
Analysis of FTIR and NMR spectra of the obtained com-
pound proved it to be the desired product. In the FTIR spec-
tra (Fig. S1, Supporting Information) it was possible to ob-
serve the relevant N-H stretching (3334 and 1533 cm-1) and 
C=O stretching (1708 cm-1) corresponding to the carbamate 
groups. In 1H NMR (Fig. S2, Supporting Information), the 
peaks for the protons of the carbamate group (N-H), with 
integration corresponding to eight protons between 6.25 and 
4.84 ppm, were present, as well as the anomeric (H-1) proton 
at 5.62 ppm and the rest of the sucrose protons between 5.53 
and 3.93 ppm. Methyl and methylene protons from the ethyl 
groups were approximately at 1 and 3 ppm, respectively, 
with integration corresponding to eight ethyl groups. In 13C 
NMR and DEPT, (Figs. S3 and S4, Supporting Information) 
it was possible to verify the presence of carbonyl carbons 
between 157 and 154 ppm. Since C-2’ of the sucrose core 
was the only quaternary carbon present, its characteristic 
shift at 102.6 ppm was observed in 13C NMR, but was not 
present in DEPT, as expected. The anomeric carbon peak of 
the glucose unit was at 91.0 ppm. The peaks for all of the 
other sucrose core carbons appeared between 78 and 62 ppm, 
and the peaks of methylene at 36 ppm and methyl carbons at 
15 ppm were corresponding to the ethyl groups. The DEPT 
spectre allowed us to distinguish the methylene groups from 
methine and methyl groups – the three primary positions of 
sucrose 1’, 6, and 6’ at 63.4, 63.3 and 62.6 ppm and the 
methylene carbons from the ethylcarbamate groups at 36 
ppm. Bi-dimensional NMR spectra (COSY, Fig. S5, and 
HMQC, Fig. S6, Supporting Information) were used as an 
aid to assess and attribute all the signals mentioned previ-
ously. Thus, the HMQC (Fig. S6) spectre allowed us to dis-
tinguish which protons were not attached to a carbon atom 
and those were attributed to the carbamate group (N-H) pro-
tons. In the COSY spectre (Fig. S5) these signals exhibited 
cross-peaks with the CH2-signals at 3.18 ppm, which con-
firmed their neighbouring positions in the carbamate groups. 
Further, in the COSY spectre were observed the cross peaks 
corresponding to the glucose core, as the one between the 
characteristic signals H-1 and H-2 at 5.62 – 4.65 ppm. Then, 
the cross peak at 4.65 – 5.30 ppm was attributed to H-2 – H-
3 interaction; H-3 – H-4 was observed at 5.30 – 4.72 ppm; 
H-4 – H-5 at 4.72 – 4.29 ppm; and H-5 – H-6 at 4.29 – 3.93 
ppm. The cross peaks corresponding to the fructose core 
appeared as follows: H-4’ – H-5’ at 5.53 – 4.09 ppm; and H-
5’ – H-6’ at 4.09 – 4.34 ppm. After attributing all the signals 
in the 1H NMR spectre, it was possible to assign all the car-
bon peaks from the corresponding cross peaks in the HMQC 
spectre. The elemental analysis results (Fig. S7, Supporting 
Information) confirmed the proposed structure, and by mass 
spectrometry it was possible to detect the expected molecular 
peak [M+Na]+ at 933.3955 mass units (Fig. S8, Supporting 
Information).  
2.2. Antibacterial Activity 
The synthesized carbamate exhibited high antibacterial 
activity against all tested bacterial species (Table 2, Figs. 2 
and 3), with MIC in the range of 0.094 - 0.280 mg/mL, and 
MBC in the range of 0.180 - 0.375 mg/mL. Comparing the 
results obtained for the synthetic compound with commercial 
antibiotic streptomycin (Table 2), it was noticed that the 
Table 2. Antibacterial activity of sucrose octa(N-ethyl)carbamate, mg/mL. 
Bacteria 
Sucrose Octa(N-
ethyl)carbamate 
MIC
[a] 
MBC
[b] 
Streptomycin 
MIC
[a] 
MBC
[b] 
Ampicillin 
MIC
[a] 
MBC
[b] 
Staphylococcus aureus 
0.18±0.006 
0.375±0.01 
0.04±0.003 
0.09±0.006 
0.25±0.03 
0.37±0.03 
Bacillus cereus 
0.094±0.000 
0.375±0.04 
0.09±0.000 
0.17±0.01 
0.25±0.03 
0.37±0.01 
Micrococcus flavus 
0.28±0.01 
0.375±0.04 
0.17±0.01 
0.34±0.02 
0.25±0.01 
0.37±0.02 
Listeria monocytogenes 
0.18±0.006 
0.375±0.04 
0.17±0.006 
0.34±0.01 
0.37±0.02 
0.49±0.09 
Pseudomonas aeruginosa 
0.094±0.002 
0.18±0.02 
0.17±0.01 
0.34±0.02 
0.74±0.02 
1.24±0.02 
Salmonella typhimurium 
0.094±0.002 
0.18±0.01 
0.17±0.000 
0.34±0.03 
0.37±0.02 
0.49±0.006 
Escherichia coli 
0.18±0.006 
0.375±0.01 
0.17±0.006 
0.34±0.006 
0.25±0.03 
0.49±0.006 
Enterobacter cloacae 
0.18±0.006 
0.375±0.000 
0.26±0.02 
0.52±0.01 
0.37±0.02 
0.74±0.02 
[a] Minimum inhibitory concentration. [b] Minimum bactericidal concentration. 
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sample exhibited similar antibacterial activity for most of the 
bacteria tested with higher antibacterial activity towards P. 
aeruginosa, S. typhimonium and E. cloacae and lower activ-
ity towards M. flavus. Compared to ampicillin (Table 2), 
compound 2 showed higher antibacterial activity and the 
only exception found was for slightly lower activity towards 
M. flavus. 
2.3. Antifungal Activity 
Sucrose octa(N-ethyl)carbamate also showed some anti-
fungal potential (Table 3, Figs. 4 and 5). Inhibitory activity 
was in the range of 0.090 - 0.375 mg/mL, while fungicidal 
effects were observed in the range from 0.180 - 1.500 
mg/mL. Sucrose octacarbamate possessed higher antifungal 
activity than bifonazole and ketoconazole against T. viride, 
and greater antifungal activity than ketoconazole towards A. 
versicolor, A. ochraceus and P. ochrochloron.  
The results showed that the growth of the various types 
of bacteria tested responded differently to the synthetic com-
pound. This indicates that it may have different modes of 
action on the different species or that the metabolism of 
some bacteria is able to overcome the effect of the com-
pound or adapt to it. It is known that Gram (+) bacteria are 
more susceptible to antimicrobial agents than Gram (-) bac-
teria and fungi are more susceptible than bacteria in general 
[24, 25]. 
2.4. Antitumor Activity and Hepatotoxicity 
The synthesized carbamate showed low activity against 
human breast, colon and cervical carcinoma cell lines, the 
latter being the most susceptible one (Table 4). Up to 400 
μg/mL, the sucrose octa(N-ethyl)carbamate did not present 
any activity towards lung and hepatocellular carcinoma cell 
lines. GI50 values were higher (lower antitumor activity) than 
the ones of the standard ellipticine. Nevertheless, it was 
noted that the tested compound did not show toxicity for 
non-tumor cells (porcine liver cells primary culture; PLP2), 
while the standard proved to be strongly hepatotoxic (2.96 
μg/mL). 
CONCLUSIONS 
In summary, a novel derivative of sucrose with all eight 
hydroxyl groups substituted with (N-ethyl)carbamate moie-
ties was synthesized and fully characterized. Synthetic pro-
cedures using microwave irradiation resulted in shorter reac-
tion times but lower yields. The antibacterial, antifungal and  
 
Fig. (2). MIC comparison of the antibacterial activity of sucrose octa(N-ethyl)carbamate, streptomycin and ampicillin. 
 
Fig. (3). MBC comparison between sucrose octa(N-ethyl)carbamate, streptomycin and ampicillin. 
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Table 3. Antifungal activity of sucrose octa(N-ethyl)carbamate, mg/mL. 
Fungi 
Sucrose Octa(N-ethyl) 
carbamate  
MIC
[a]
 MFC
[b] 
Bifonazole 
MIC
[a]
 MFC
[b] 
Ketoconazole 
MIC
[a]
 MFC
[b] 
Aspergillus fumigatus 
0.375 ± 0.001 
0.75 ± 0.000 
0.15 ± 0.03 
0.20 ± 0.03 
0.20 ± 0.00 
0.50 ± 0.10 
Aspergillus versicolor 
0.18 ± 0.01 
0.375 ± 0.01 
0.10 ± 0.06 
0.20 ± 0.06 
0.20 ± 0.06 
0.50 ± 0.06 
Aspergillus ochraceus 
0.375 ± 0.01 
0.75 ± 0.03 
0.15 ± 0.03 
0.20 ± 0.00 
1.50 ± 0.00 
2.0 ± 0.30 
Aspergillus niger 
0.375 ± 0.01 
0.75 ± 0.00 
0.15 ± 0.03 
0.20 ± 0.06 
0.20 ± 0.03 
0.50 ± 0.03 
Trichoderma viride 
0.09 ± 0.006 
0.18 ± 0.000 
0.15 ± 0.03 
0.20 ± 0.00 
1.0 ± 0.00 
1.0 ± 0.30 
Penicillium funiculosum 
0.375 ± 0.04 
0.75 ± 0.03 
0.20 ± 0.06 
0.25 ± 0.03 
0.20 ± 0.03 
0.50 ± 0.00 
Penicillium ochrochloron 
0.375 ± 0.04 
0.75 ± 0.08 
0.20 ± 0.06 
0.25 ± 0.03 
2.5 ± 0.30 
3.5 ± 0.10 
Penicillium verrucosum 
0.75 ± 0.000 
1.5 ± 0.300 
0.10 ± 0.00 
0.20 ± 0.00 
0.20 ± 0.00 
0.30 ± 0.00 
[a] Minimum inhibitory concentration. [b] Minimum fungal concentration.  
 
Fig. (4). MIC comparison of the antifungal activity of sucrose octa(N-ethyl)carbamate, bifonazole and ketoconazole. 
 
Fig. (5). MFC comparison between sucrose octa(N-ethyl)carbamate, bifonazole and ketoconazole. 
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Table 4. Antitumor activity of sucrose octa(N-ethyl)carbamate, μg/mL. 
Cell Line 
Sucrose Octa(N-ethyl)carbamate 
GI50
[a] 
Ellipticine 
MCF7 (human breast carcinoma) 357.20±14.12 0.91±0.04 
NCI-H460 (human lung carcinoma) > 400 1.42±0.00 
HCT15 (human colon carcinoma) 332.43±11.19 1.91±0.06 
HeLa (human cervical carcinoma) 282.67±3.97 1.14±0.21 
HepG2 (human hepatocellular carcinoma) > 400 3.22±0.67 
PLP2 (non-tumor porcine liver primary cells) > 400 2.06±0.03 
[a] Growth inhibition by 50 %.  
 
cytotoxic activities of sucrose octa(N-ethyl)carbamate were 
tested with the view to potential applications. It exhibited 
higher antibacterial activity than streptomycin against all 
Gram (-) bacteria, with the exception of E. coli, where this 
potential was almost the same. It was obvious that the com-
pound tested possesses a wide spectrum of activity, depend-
ing on the bacterial and fungal species. It exhibited moderate 
to low antitumor potential (towards human breast, lung, co-
lon, cervical, hepatocellular carcinoma cell lines, MCF7, 
NCI-H460, HCT15, HeLa and HepG2 cells respectively), 
but without hepatotoxicity towards non-tumor procine liver 
primary cells, PLP2. 
MATERIALS AND METHODS 
General Methods 
The 1H NMR (400 Hz) and 13C NMR (100 Hz) were re-
corded on Bruker ARX 400 spectrometer in CDCl3 solutions. 
Chemical shift values () are expressed in parts per million 
and reported downfield from TMS (0.00 ppm). Melting point 
was determined on Electrothermal Melting Point Apparatus. 
Optical rotation was measured in chloroform solution using 
an AA-1000 Polarimeter Optical Activity LTD (0.5 dm cell) 
at 589 nm. FTIR specter was recorded on a Bruker Tensor 27 
spectrometer in KBr dispersion. Mass spectra were recorded 
on a MALDI-TOF (Matrix-Assisted Laser Desorption and 
Ionization Time of Flight) spectrometer (Voyager-DETM 
Pro Workstation model). The microwave-assisted syntheses 
was performed as previously described [26]. Flash chroma-
tography was performed on silica gel (Merck, 200-400 
mesh). Pyridine and triethylamine were distilled from KOH 
prior to use [27].  
Sucrose Octa(N-ethyl)carbamate 
Conventional synthesis: Sucrose (1.00 g, 2.92 mmol) was 
dissolved in pyridine (15 mL) with magnetic stirring and 
under inert atmosphere (argon). Triethylamine (150 mmol, 
2.1 mL) was added and after 30 min the reaction mixture 
was cooled in an ice bath. Ethyl isocyanate (351 mmol, 2.8 
mL) was then added dropwise within 15 min. The reaction 
mixture was let to reach r.t. After 28 h all of the sucrose had 
reacted (TLC, eluent, acetone/metanol/water 5/2/1) and the 
pyridine was evaporated azeotropically using toluene. The 
crude product was purified by flash chromatography (ether, 
then ethyl acetate) to afford the desired product as a white 
solid (2.38 g, 89 %). 
Microwave Synthesis 
Sucrose (1.00 g, 2.92 mmol) was dissolved in pyridine 
(15 mL) and triethylamine (150 mmol, 2.1 mL) was added 
with magnetic stirring and under an inert atmosphere (ar-
gon). After 30 minutes the reaction mixture was cooled in an 
ice bath and ethyl isocyanate (351 mmol, 2.8 mL) was added 
dropwise within 15 min. The reaction mixture was subjected 
to microwave irradiation (max 300 W at constant tempera-
ture 105 °C) for 15 minutes. The pyridine was evaporated 
using toluene, and the crude product was purified by flash 
chromatography (ether, then ethyl acetate) to afford the de-
sired compound as a white solid (1.84 g, 69 %). 
 
 D
24
 +14.7 (c 1.00, CHCl3); mp 113-115 °C; FTIR (K-
Br, cm-1) max: 3334 (N-H stretch), 2975, 2935 (C-H stretch), 
1708 (C=O stretch), 1533 (N-H stretch), 1452, 1381, 1359 
(C-H stretch), 1250 (N-CO-O assymetric stretch), 969 (N-
CO-O symetric stretch); 1H NMR (CDCl3, 400 MHz)  
(ppm): 6.25 (1H, s, N-H), 6.10 (1H, s, N-H), 5.80 (2H, s, N-
H), 5.62 (1H, s, H-1), 5.53 (2H, s, H-3’, 4’), 5.32-5.28 (1H, 
m, H-3), 5.09 (1H, s, N-H), 4.93-4.91 (2H, m, N-H), 4.84 
(1H, s, N-H), 4.72 (1H, t, J = 9.78 Hz, H-4), 4.65 (1H, d, J = 
7.7 Hz, H-2), 4.40-4.23 (5H, m, H-5, 2H-1’, 2H-6’), 4.11-
4.08 (2H, m, H-5’, 6), 3.93 (1H, t, J = 10.4 Hz, H-6), 3.19-
3.17 (16H, m, CH2), 1.18-1.07 (24H, m, CH3); 13C NMR 
(CDCl3, 100 MHz)  (ppm): 156.5, 156.4, 155.8, 155.7, 
155.0, 154.9, 154.6 (C=O), 102.6 (C-2’), 91.0 (C-1), 78.2 
(C-5’), 75.6, 72.8 (C-3’,C-4’), 71.4 (C-2), 70.8 (C-3), 69.8 
(C-4), 68.3 (C-5), 63.4, 63.3, 62.6 (C-1’, C-6, C-6’), 36.0, 
35.9, 35.8 (CH2), 15.2, 15.0, 14.9, 14.8, 14.6 (CH3); Anal. 
calcd. for C36H62N8O19: C, 47.47; H, 6.86; N, 12.30; found: 
C, 47.60; H, 6.69; N, 12.65. MALDI-TOF MS m/z calcd. for 
C36H62N8O19Na ([M+Na]+) 933.4023; found: 933.3955. 
Antibacterial Activity 
The Gram-positive bacteria Staphylococcus aureus 
(ATCC 6538), Bacillus cereus (clinical isolate), Listeria 
monocytogenes (NCTC 7973), and Micrococcus flavus 
(ATCC 10240), and the Gram-negative bacteria Pseudo-
monas aeruginosa (ATCC 27853), Escherichia coli (ATCC 
35210), Salmonella typhimurium (ATCC 13311), and En-
28     Medicinal Chemistry, 2016, Vol. 12, No. 1 Raposo et al. 
terobacter cloacae (human isolate), were used. The antibac-
terial assay was carried out by a microdilution method as 
previously described [28, 29]. 
Antifungal Activity 
Aspergillus fumigatus (human isolate), Aspergillus versi-
color (ATCC 11730), Aspergillus ochraceus (ATCC 12066), 
Aspergillus niger (ATCC 6275), Trichoderma viride (IAM 
5061), Penicillium funiculosum (ATCC 36839), Penicillium 
ochrochloron (ATCC 9112) and Penicillium verrucosum 
var. cyclopium (food isolate), were used. Commercial fungi-
cides, bifonazole (Srbolek, Belgrade, Serbia) and ketocona-
zole (Zorkapharma, abac, Serbia), were used as positive 
controls (1-3000 g/mL). To investigate the antifungal activ-
ity, a modified microdilution technique was used [30, 31]. 
Antitumor Activity and Hepatotoxicity 
Five human tumor cell lines were used: MCF-7 (breast 
adenocarcinoma), NCI-H460 (non-small cell lung cancer), 
HCT-15 (colon carcinoma), HeLa (cervical carcinoma) and 
HepG2 (hepatocellular carcinoma). The tests were performed 
as described in [32]. GI50 values (sample concentration that 
inhibited 50 % of the net cell growth) were determined and 
ellipticine was used as standard. 
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